Evidence map›Paper›PMID 26899802›Full record

ArticleAddiction (Abingdon, England)2016

Estimating demand for primary care-based treatment for substance and alcohol use disorders.

Colleen L Barry, Andrew J Epstein, David A Fiellin, Liana Fraenkel, Susan H Busch

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Gastrointestinal Conditions and New Diagnosis of Alcohol Use Disorder.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Colleen L BarryDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Andrew J EpsteinLeonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
David A FiellinDepartment of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Liana FraenkelDepartment of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Susan H BuschDepartment of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Expanding Treatment of Opioid Dependence Among the Privately InsuredR01DA026414 · NIDA · YALE UNIVERSITY · PI BUSCH, SUSAN H · 2009 to 2012
$1.7M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS R01 DA026414
6 · The paper itself

Abstract

BACKGROUND AND

aimsWhile there is broad recognition of the high societal costs of substance use disorders (SUD), treatment rates are low. We examined whether, in the United States, participants with substance or alcohol use disorder would report a greater willingness to enter SUD treatment located in a primary care setting (primary care) or more commonly found specialty care setting in the United States (usual care).

designRandomized survey-embedded experiment.

settingUS web-based research panel in which participants were randomized to read one-paragraph vignettes describing treatment in usual care (specialty drug or alcohol treatment center), primary care or collaborative care within a primary care setting.

participantsA total of 42 451 panelists aged 18+ were screened for substance or alcohol use disorder using validated diagnostic criteria. Participants included 344 with a substance use disorder and 634 with an alcohol use disorder not in treatment with no prior treatment history. MEASURES: Willingness to enter treatment across vignettes by condition.

findingsAmong participants with a substance use disorder, 24.6% of those randomized to usual care reported being willing to enter drug treatment compared with 37.2% for primary care [12.6 percentage point difference; 95% confidence interval (CI) = 0.8, 24.4) and 34.0% for collaborative care (9.4 percentage point difference; 95% CI = -2.0, 20.8). Among participants with an alcohol use disorder, 17.6% of those randomized to usual care reported being willing to enter alcohol treatment compared with 20.3% for primary care (2.6 percentage point difference; 95% CI = -4.9, 10.1) and 20.8% for collaborative care (3.1 percentage point difference; 95% CI = -4.3, 10.6). The most common reason for not being willing to enter drug (63%) and alcohol (78%) treatment was the belief that treatment was not needed.

conclusionsIn the United States, people diagnosed with substance or alcohol use disorders appear to be more willing to enter treatment in a primary care setting than in a specialty drug treatment center. Expanding availability of primary care-based substance use disorder treatment could increase treatment rates in the United States.

Indexed as

Health Services Needs and DemandPatient Acceptance of Health CarePrimary Health CareAdolescentAdultAlcoholismFemaleHumansMaleMiddle AgedSubstance-Related DisordersSurveys and QuestionnairesUnited StatesYoung AdultAlcohol use disorderscollaborative careeconomicsfinancingprimary caresubstance use disorders

Identifiers

PMID26899802
PMCPMC4940268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.